chr8-144513139-C-G

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_004260.4(RECQL4):​c.2464-1G>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000795 in 1,558,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000075 ( 0 hom. )

Consequence

RECQL4
NM_004260.4 splice_acceptor, intron

Scores

2
2
Splicing: ADA: 0.01681
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 6.88

Publications

8 publications found
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
  • Baller-Gerold syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • Rothmund-Thomson syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Rothmund-Thomson syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • osteosarcoma
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • rapadilino syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.6, offset of -11, new splice context is: ccaccccaccctcatgaaAGttg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-144513139-C-G is Pathogenic according to our data. Variant chr8-144513139-C-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 94889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RECQL4NM_004260.4 linkc.2464-1G>C splice_acceptor_variant, intron_variant Intron 14 of 20 ENST00000617875.6 NP_004251.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RECQL4ENST00000617875.6 linkc.2464-1G>C splice_acceptor_variant, intron_variant Intron 14 of 20 1 NM_004260.4 ENSP00000482313.2
RECQL4ENST00000621189.4 linkc.1393-1G>C splice_acceptor_variant, intron_variant Intron 13 of 19 1 ENSP00000483145.1
RECQL4ENST00000534626.6 linkc.634-1G>C splice_acceptor_variant, intron_variant Intron 5 of 7 5 ENSP00000477457.1
ENSG00000265393ENST00000580385.1 linkn.271+302C>G intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.000120
AC:
18
AN:
149460
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000975
GnomAD2 exomes
AF:
0.000105
AC:
21
AN:
200494
AF XY:
0.0000922
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00310
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000110
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000752
AC:
106
AN:
1409346
Hom.:
0
Cov.:
66
AF XY:
0.0000749
AC XY:
52
AN XY:
694262
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32618
American (AMR)
AF:
0.00
AC:
0
AN:
41370
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
68
AN:
23074
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38896
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78334
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46970
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5530
European-Non Finnish (NFE)
AF:
0.0000249
AC:
27
AN:
1084390
Other (OTH)
AF:
0.000189
AC:
11
AN:
58164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000120
AC:
18
AN:
149460
Hom.:
0
Cov.:
34
AF XY:
0.000124
AC XY:
9
AN XY:
72842
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39886
American (AMR)
AF:
0.00
AC:
0
AN:
14836
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5072
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10270
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
308
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67840
Other (OTH)
AF:
0.000975
AC:
2
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000386
Hom.:
0
Bravo
AF:
0.000110
ExAC
AF:
0.0000420
AC:
5

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Jul 03, 2024
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31589614, 32775946, 18716613, 30687805, 34869606, 35833951, 31794323, 33077847, 37331604, 38413718, 29625052, 36451132, 12734318, 31887429, 36744932) -

Mar 04, 2013
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RECQL4: PVS1 -

Rothmund-Thomson syndrome type 2 Pathogenic:2
Aug 01, 2023
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The RECQL4 c.2464-1G>C intronic change results in a G to C substitution at the -1 position of intron 14 of the RECQL4 gene and is predicted to disrupt the acceptor splice site. This variant has been identified in the homozygous state in siblings with clinical features of Rothmund-Thomson syndrome (PMID: 12734318), and in the compound heterozygous state in an unrelated individual with clinical features of Rothmund-Thomson syndrome (PMID: 18716613). It has also been identified as heterozygous in at least one individual with leiomyosarcoma (PMID: 29625052). This variant has a maximum founder subpopulation frequency of 0.31% and a maximum non-founder subpopulation frequency of 0.0011% in gnomAD v2.1.1. In summary, this variant meets criteria to be classified as pathogenic. -

Feb 09, 2023
New York Genome Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The homozygous c.2464-1G>C variant identified in the RECQL4 gene is a canonical splice variant within intron 14/20, and is predicted to lead to aberrant splicing by in silico algorithm SpliceAI (delta score: 0.98 for an acceptor loss -1bp). This variant is found with low frequency in population databases (gnomADv2.1.1, gnomADv3.2.1, BRAVO-TOPMed, All of Us) with highest allele frequency in BRAVO-TOPMed (29 heterozygotes, 0 homozygotes, allele frequency: 1.10e-4), suggesting it is not a common benign variant in the populations represented in those databases. The c.2464-1G>C variant in RECQL4 is reported in ClinVar as Pathogenic (VarID:94889; 2 stars, 3 submissions, no conflicts), and has been previously reported in homozygous state in two siblings with a clinical diagnosis of Rothmund-Thomson syndrome [PMID:12734318] and in compound heterozygosity with a different canonical splice variant in an unrelated patient with a clinical diagnosis of Rothmund-Thomson syndrome [PMID:18716613]. Given its expected deleterious nature, low frequency in population databases, and presence in several affected individuals in the literature in both homozygous state and in compound heterozygosity, the homozygous c.2464-1G>C variant identified in the RECQL4 gene is reported as Pathogenic. -

Baller-Gerold syndrome;C1849453:Rapadilino syndrome;C5203410:Rothmund-Thomson syndrome type 2 Pathogenic:1
Oct 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Baller-Gerold syndrome Pathogenic:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects an acceptor splice site in intron 14 of the RECQL4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs398124117, gnomAD 0.3%). Disruption of this splice site has been observed in individual(s) with clinical features of Rothmund-Thomson syndrome (PMID: 12734318, 18716613, 29625052). It has also been observed to segregate with disease in related individuals. This variant is also known as g.4615G>C. ClinVar contains an entry for this variant (Variation ID: 94889). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Uncertain
0.040
CADD
Benign
23
DANN
Uncertain
0.99
FATHMM_MKL
Pathogenic
0.98
D
PhyloP100
6.9
GERP RS
4.9
PromoterAI
-0.0076
Neutral
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.017
dbscSNV1_RF
Benign
0.042
SpliceAI score (max)
0.98
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.98
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398124117; hg19: chr8-145738522; COSMIC: COSV52882660; API